A detailed history of Ever Source Wealth Advisors, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,011 shares of IBRX stock, worth $2,557. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,011
Previous 968 4.44%
Holding current value
$2,557
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

BUY
$1.89 - $3.44 $81 - $147
43 Added 4.44%
1,011 $2,000
Q1 2025

May 13, 2025

BUY
$2.32 - $3.9 $568 - $955
245 Added 33.89%
968 $2,000
Q4 2023

Feb 09, 2024

BUY
$1.25 - $5.21 $903 - $3,766
723 New
723 $3,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.01B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.